| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > PPC Publishing > Google Adsense and Content - Where To Now? |
|
Digg It - Google Adsense and Content - Where To Now?
From quiet beginnings, Google Adsense has developed into a great tool that benefits advertisers and webmasters alike - not to mention Google itself. But beyond its phenomenal growth comes something that could be more far-reaching. Adsense has spawned a whole new online According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product culture and given new meanings to concepts that have been around on the net for years. I can remember in 1988, when I was developing Health News NZ out of a long-term interest in natural health remedies, reading tutorial articles by Ken Evoy on the importance of creati ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in g "content-rich" sites to draw in potential customers. There could be no argument with his thesis that the material in these sites would establish a relationship with visitors, and put them in the frame of mind to buy. It was all about building trust and good relations. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. I didn't have products to sell, but Ken's argument had a ring of truth that has stayed with me ever since - and it has proved to be prophetic. At the time, I realised I was creating a "content-rich site" of exactly the kind Ken had in mind, and though my motives were here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe imply to disseminate information, I felt kind of glad that I was on the right track. Hundreds of other people were quietly doing the same - bringing their passions online, putting up information about whatever they loved to do, to the point where you can now type almos d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro any word into a search engine and find that someone knowledgeable has spent many hours creating an online showcase to explain their "take" on the subject. Most of these sites came from pure love, and they are a tribute both to the Internet and the true passion of the h ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc man soul. But thanks to Adsense, "content" has taken on a whole new meaning. Suddenly the possibility of earning a passive income from the Google phenomenon has caught on like wildfire among people interested mainly in dollars. These people are rushing to own content-r easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ch niche sites - even if they know not one detail about those all-important "niches" that are now being identified as the latest in cash machines. Make no mistake. We really are talking "quantity" rather than "quality" here. A sub-culture has sprung up almost from nowh nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re marketing ready-made sites and ready-made private label content to enable entrepreneurs to cash in big time on the best keywords in the new Google gravy train. People are falling over each other in droves to throw their money into the ring. It's a developer's dream and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ome true. We now have software that will shell out a fully-fledged website in half an hour (and people expecting to bring online at least 5 of these a week), packages of ready-written Private Label Rights articles, membership sites where for a monthly fee you can get P ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi R packages on any topic that ranks high in keyword analyses, or ready-made content-rich sites already fitted out with Google Adsense codes. I recently visited a freelancing site where someone was looking to have content created at the rate of 40 short articles a day. HM ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a M... To top it off, people are coming up with software that at the click of a button will personalise PLR articles so you don't get caught up in Google's "duplicate content" dredge. Look around and you will find sites - some very substantial in terms of page numbers - dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod that are nothing more than thinly disguised venues for the display of adverts. They have a "search" or "directory" flavour, and the content on each page is just enough to enable Google's wily spiders to figure out what ads they should send across the ether today. Where cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin S all this heading to? Probably only time will tell, but it's interesting to speculate. After all, this is the Information Age - only who said it was going to be the Information Cloning Age? Perhaps the hope is that by the time someone strikes their fifth cloned site f tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen r the day, they will be so desperate for something innovative that they go into a frenzy of ad clicking - aah just what the site is there for! Well, maybe the Internet is big enough to stand this onslaught; maybe we have so many billions of users hungry for information t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel and finding it through so many different channels that the duplication will never be noticed. I'd like to think, though, that discerning users (aren't we all discerning when it comes to things that waste our time?) will soon sort the wheat from the chaff and gravitate ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o sites that are genuinely content-rich in Ken Evoy's original sense. You can amplify and enrich individual content with feeds and judicial use of "Private Label Content" here and there. But nothing beats the special insights and experiences of a site owner whose involv y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ment with the subject matter goes more than skin-deep. Speaking personally, Google Adsense is a joy to anyone who has laboured long and hard on developing unique copy for a true information site. I am sure there are many like me who feel the same. It's wonderful to fin . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de a way of helping your readers that also brings in a return for the hours of work involved - but moneymaking is not, and never was, the main aim of the exercise. I believe one of the most important keys to success on the net is still the personal touch. Visitors can so elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip n smell out whether a site "comes from the heart" or not and I think in the fullness of time the use of genuine content will still be the key to building a clientele of lasting visitors. Ken was right, of course - the true "Content" concept is still in the driving seat tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Selling Glow Sticks for a Fundraiser How To Know You're On A Winner Exchanging Links – Get The Right Sites To Link To Your Website
|